Biotech

All Articles

Aligos advertises stage 2 MASH succeed, reducing liver body fat up to 46%

.Aligos Rehabs is heralding a midstage gain in metabolic-dysfunction associated steatohepatitis (MAS...

Basilea credit ratings $268M BARDA financing for antifungals, anti-biotics

.Basilea Pharmaceutica's work building new antifungals has actually received a substantial increase ...

Capricor sells Europe rights to late-stage DMD therapy for $35M

.Having currently gathered up the U.S. liberties to Capricor Therapies' late-stage Duchenne muscular...

FDA fragments adcomm for Applied's rare ailment medication

.After dismissing the decision date for Applied Therapeutics' metabolic condition medication govores...

Novo inks $600M NanoVation deal to research hereditary medications ex-liver

.Novo Nordisk is continuing its own press in to hereditary medicines, accepting to pay NanoVation Th...

Innovent hyperlinks cytokine to colon cancer cells actions

.Innovent Biologics has actually created the scenario that its own checkpoint inhibitor-cytokine com...

Merck, Daiichi ADC strikes target in phase 3 lung cancer cells study

.A stage 3 test of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate (A...

Rakovina deepens artificial intelligence focus with collab to select cancer cells intendeds

.5 months after Rakovina Therapies pivoted towards expert system, the cancer-focused biotech has act...

Ascendis' dwarfism drug hits in phase 3, endangers BioMarin

.Ascendis Pharma has actually emerged as a potential risk to BioMarin's Voxzogo, stating stage 3 dev...

Despite ph. 3 miss out on, Alkeus views course ahead of time for eye ailment asset

.Though Alkeus Pharmaceuticals' dental eye condition possession stopped working to dramatically less...